Literature DB >> 30316645

Role of inflammatory signaling in atrial fibrillation.

Larry Scott1, Na Li2, Dobromir Dobrev3.   

Abstract

Atrial fibrillation (AF), the most prevalent arrhythmia, is often associated with enhanced inflammatory response. Emerging evidence points to a causal role of inflammatory signaling pathways in the evolution of atrial electrical, calcium handling and structural remodeling, which create the substrate of AF development. In this review, we discuss the clinical evidence supporting the association between inflammatory indices and AF development, the molecular and cellular mechanisms of AF, which appear to involve multiple canonical inflammatory pathways, and the potential of anti-inflammatory therapeutic approaches in AF prevention/treatment.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; IL-1β; Inflammasome; Inflammation; NFκB; TNF-α

Mesh:

Substances:

Year:  2018        PMID: 30316645      PMCID: PMC6447485          DOI: 10.1016/j.ijcard.2018.10.020

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  74 in total

1.  A review of current surgical treatment of patients with atrial fibrillation.

Authors:  Zachary J Edgerton; James R Edgerton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-07

2.  The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.

Authors:  Eleonora Mezzaroma; Stefano Toldo; Daniela Farkas; Ignacio M Seropian; Benjamin W Van Tassell; Fadi N Salloum; Harsha R Kannan; Angela C Menna; Norbert F Voelkel; Antonio Abbate
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

Review 3.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 4.  Calcium Signaling and Cardiac Arrhythmias.

Authors:  Andrew P Landstrom; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2017-06-09       Impact factor: 17.367

Review 5.  Atrial fibrillation pathophysiology: implications for management.

Authors:  Yu-ki Iwasaki; Kunihiro Nishida; Takeshi Kato; Stanley Nattel
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

Review 6.  The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.

Authors:  Gonzalo J Martínez; David S Celermajer; Sanjay Patel
Journal:  Atherosclerosis       Date:  2017-12-25       Impact factor: 5.162

Review 7.  Novel molecular targets for atrial fibrillation therapy.

Authors:  Dobromir Dobrev; Leif Carlsson; Stanley Nattel
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

Review 8.  Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?

Authors:  Manyi Ren; Xiuzhen Li; Li Hao; Jingquan Zhong
Journal:  Ann Med       Date:  2015-05-18       Impact factor: 4.709

9.  Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis.

Authors:  Na Wu; Bin Xu; Ying Xiang; Long Wu; Yao Zhang; Xiangyu Ma; Shifei Tong; Maoqing Shu; Zhiyuan Song; Yafei Li; Li Zhong
Journal:  Int J Cardiol       Date:  2013-09-08       Impact factor: 4.164

Review 10.  Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes.

Authors:  Basil S Karam; Alejandro Chavez-Moreno; Wonjoon Koh; Joseph G Akar; Fadi G Akar
Journal:  Cardiovasc Diabetol       Date:  2017-09-29       Impact factor: 9.951

View more
  23 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

3.  Behçet's disease: A (silk) route to atrial fibrillation?

Authors:  Santosh V Suryavanshi; Na Li
Journal:  Int J Cardiol       Date:  2019-07-19       Impact factor: 4.164

4.  Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.

Authors:  Anke C Fender; Sonja Kleeschulte; Svenja Stolte; Katja Leineweber; Markus Kamler; Johannes Bode; Na Li; Dobromir Dobrev
Journal:  Basic Res Cardiol       Date:  2020-01-07       Impact factor: 17.165

5.  MicroRNA-205-5p plays a suppressive role in the high-fat diet-induced atrial fibrosis through regulation of the EHMT2/IGFBP3 axis.

Authors:  Zezhou Xiao; Yu Xie; Fangze Huang; Jie Yang; Ximao Liu; Xuefeng Lin; Peng Zhu; Shaoyi Zheng
Journal:  Genes Nutr       Date:  2022-07-20       Impact factor: 4.423

Review 6.  Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants.

Authors:  Anke C Fender; Reza Wakili; Dobromir Dobrev
Journal:  Pharmacol Res       Date:  2019-05-02       Impact factor: 7.658

Review 7.  Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Authors:  Stanley Nattel; Philip T Sager; Jörg Hüser; Jordi Heijman; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

Review 8.  The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation.

Authors:  Xiaolei Wang; Xiaohui Chen; Dobromir Dobrev; Na Li
Journal:  Pflugers Arch       Date:  2021-01-28       Impact factor: 3.657

Review 9.  Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation.

Authors:  Ramón Rodrigo; Jaime González-Montero; Camilo G Sotomayor
Journal:  Biomedicines       Date:  2021-05-30

Review 10.  Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.

Authors:  Kun Xiang; Muhammad Akram; Walaa Fikry Elbossaty; Jinfu Yang; Chengming Fan
Journal:  Heart Fail Rev       Date:  2021-07-12       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.